Άρθρα με εντολές δημόσιας πρόσβασης - Kelly PhillipsΜάθετε περισσότερα
Δεν είναι διαθέσιμο πουθενά: 8
Έλεγχος
10-year performance of four models of breast cancer risk: a validation study
MB Terry, Y Liao, AS Whittemore, N Leoce, R Buchsbaum, N Zeinomar, ...
The Lancet Oncology 20 (4), 504-517, 2019
Εντολές: US National Institutes of Health, National Health and Medical Research …
Έλεγχος
Contralateral prophylactic mastectomy (CPM): a systematic review of patient reported factors and psychological predictors influencing choice and satisfaction
B Ager, P Butow, J Jansen, KA Phillips, D Porter, CPMDAA Group
The Breast 28, 107-120, 2016
Εντολές: National Health and Medical Research Council, Australia
Έλεγχος
Risk of dementia in older breast cancer survivors: a population‐based cohort study of the association with adjuvant chemotherapy
NN Baxter, SB Durham, KA Phillips, EB Habermann, BA Virning
Journal of the American Geriatrics Society 57 (3), 403-411, 2009
Εντολές: Canadian Institutes of Health Research
Έλεγχος
Consumer and clinician perspectives on personalising breast cancer prevention information
LA Keogh, E Steel, P Weideman, P Butow, IM Collins, JD Emery, ...
The Breast 43, 39-47, 2019
Εντολές: National Health and Medical Research Council, Australia
Έλεγχος
Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy
B Ager, J Jansen, D Porter, KA Phillips, R Glassey, N Rankin, T Musiello, ...
The Breast 40, 156-164, 2018
Εντολές: National Health and Medical Research Council, Australia
Έλεγχος
Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?
KA Phillips, EJ Steel, I Collins, J Emery, M Pirotta, GB Mann, P Butow, ...
Australian Journal of Primary Health 22 (3), 255-261, 2016
Εντολές: National Health and Medical Research Council, Australia, Cancer Research UK
Έλεγχος
Breast cancer chemoprevention: use and views of Australian women and their clinicians
C Macdonald, CM Saunders, LA Keogh, M Hunter, D Mazza, ...
Cancer Prevention Research 14 (1), 131-144, 2021
Εντολές: US National Institutes of Health, National Health and Medical Research …
Έλεγχος
Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants—Caution Needed—Reply
YH Choi, MB Terry, L Briollais
JAMA oncology 7 (9), 1402-1402, 2021
Εντολές: National Health and Medical Research Council, Australia
Διαθέσιμο κάπου: 120
Έλεγχος
Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ...
Jama 317 (23), 2402-2416, 2017
Εντολές: US National Institutes of Health, National Health and Medical Research …
Έλεγχος
Association analysis identifies 65 new breast cancer risk loci
K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ...
Nature 551 (7678), 92-94, 2017
Εντολές: US National Institutes of Health, Canadian Institutes of Health Research …
Έλεγχος
Key steps for effective breast cancer prevention
KL Britt, J Cuzick, KA Phillips
Nature Reviews Cancer 20 (8), 417-436, 2020
Εντολές: Cancer Research UK
Έλεγχος
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy
HCF Moore, JM Unger, KA Phillips, F Boyle, E Hitre, D Porter, PA Francis, ...
New England Journal of Medicine 372 (10), 923-932, 2015
Εντολές: US National Institutes of Health
Έλεγχος
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ...
Jama 313 (13), 1347-1361, 2015
Εντολές: US National Institutes of Health, Cancer Research UK, National Institute for …
Έλεγχος
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ...
Nature genetics 49 (5), 680-691, 2017
Εντολές: US National Institutes of Health, Canadian Institutes of Health Research …
Έλεγχος
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
H Zhang, TU Ahearn, J Lecarpentier, D Barnes, J Beesley, G Qi, X Jiang, ...
Nature genetics 52 (6), 572-581, 2020
Εντολές: US National Institutes of Health, National Health and Medical Research …
Έλεγχος
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
Εντολές: US National Institutes of Health, National Health and Medical Research …
Έλεγχος
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy
LJ Pierce, KA Phillips, KA Griffith, S Buys, DK Gaffney, MS Moran, ...
Breast cancer research and treatment 121, 389-398, 2010
Εντολές: US National Institutes of Health
Έλεγχος
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
KA Phillips, RL Milne, MA Rookus, MB Daly, AC Antoniou, S Peock, ...
Journal of clinical oncology 31 (25), 3091-3099, 2013
Εντολές: US National Institutes of Health, National Health and Medical Research …
Έλεγχος
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
CE Geyer Jr, JE Garber, RD Gelber, G Yothers, M Taboada, L Ross, ...
Annals of oncology 33 (12), 1250-1268, 2022
Εντολές: US National Institutes of Health, National Institute for Health Research, UK
Έλεγχος
CHEK2*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second …
M Weischer, BG Nordestgaard, P Pharoah, MK Bolla, H Nevanlinna, ...
Journal of clinical oncology 30 (35), 4308-4316, 2012
Εντολές: US National Institutes of Health, Cancer Research UK
Τα στοιχεία έκδοσης και χρηματοδότησης καθορίζονται αυτόματα από ένα πρόγραμμα υπολογιστή